» Articles » PMID: 20133864

Accelerated Carcinogenesis Following Liver Regeneration is Associated with Chronic Inflammation-induced Double-strand DNA Breaks

Overview
Specialty Science
Date 2010 Feb 6
PMID 20133864
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and is considered to be the outcome of chronic liver inflammation. Currently, the main treatment for HCC is surgical resection. However, survival rates are suboptimal partially because of tumor recurrence in the remaining liver. Our aim was to understand the molecular mechanisms linking liver regeneration under chronic inflammation to hepatic tumorigenesis. Mdr2-KO mice, a model of inflammation-associated cancer, underwent partial hepatectomy (PHx), which led to enhanced hepatocarcinogenesis. Moreover, liver regeneration in these mice was severely attenuated. We demonstrate the activation of the DNA damage-response machinery and increased genomic instability during early liver inflammatory stages resulting in hepatocyte apoptosis, cell-cycle arrest, and senescence and suggest their involvement in tumor growth acceleration subsequent to PHx. We propose that under the regenerative proliferative stress induced by liver resection, the genomic unstable hepatocytes generated during chronic inflammation escape senescence and apoptosis and reenter the cell cycle, triggering the enhanced tumorigenesis. Thus, we clarify the immediate and long-term contributions of the DNA damage response to HCC development and recurrence.

Citing Articles

A Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer.

Prime S, Darski P, Hunter K, Cirillo N, Parkinson E Int J Mol Sci. 2024; 25(7).

PMID: 38612901 PMC: 11012950. DOI: 10.3390/ijms25074092.


Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.

Pinto T, Saito H, Nourani C, Ataide E, Boin I, Lourenco G Gastroenterology Res. 2024; 17(1):23-31.

PMID: 38463146 PMC: 10923249. DOI: 10.14740/gr1689.


Defective Homologous Recombination Repair By Up-Regulating Lnc-HZ10/Ahr Loop in Human Trophoblast Cells Induced Miscarriage.

Chen W, Mi C, Zhang Y, Yang Y, Huang W, Xu Z Adv Sci (Weinh). 2024; 11(13):e2207435.

PMID: 38286681 PMC: 10987163. DOI: 10.1002/advs.202207435.


Crystalline silica-exposed human lung epithelial cells presented enhanced anchorage-independent growth with upregulated expression of BRD4 and EZH2 in autocrine and paracrine manners.

Katabami M, Kinoshita I, Ariga S, Shimizu Y, Dosaka-Akita H PLoS One. 2023; 18(5):e0285354.

PMID: 37146018 PMC: 10162546. DOI: 10.1371/journal.pone.0285354.


Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy.

Weber N, Odriozola L, Ros-Ganan I, Garcia-Porrero G, Salas D, Argemi J JHEP Rep. 2023; 5(5):100713.

PMID: 37096142 PMC: 10121466. DOI: 10.1016/j.jhepr.2023.100713.


References
1.
Echave Llanos J, BADRAN A, Moreno F . Inhibiting effect of a hepatoma extract on the mitotic rate of regenerating liver. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986; 51(1):17-27. DOI: 10.1007/BF02899012. View

2.
Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J . Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Mol Cancer Res. 2007; 5(11):1159-70. DOI: 10.1158/1541-7786.MCR-07-0172. View

3.
Llovet J, Schwartz M, Mazzaferro V . Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25(2):181-200. DOI: 10.1055/s-2005-871198. View

4.
Farazi P, DePinho R . Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006; 6(9):674-87. DOI: 10.1038/nrc1934. View

5.
Mochan T, Venere M, DiTullio Jr R, Halazonetis T . 53BP1, an activator of ATM in response to DNA damage. DNA Repair (Amst). 2004; 3(8-9):945-52. DOI: 10.1016/j.dnarep.2004.03.017. View